- Semaglutide linked to lower psychiatric risk
- Liraglutide modest; others no effect
- Lower risk of depression, anxiety, substance use
- Lower risk vs empagliflozin; higher vs some agents
- Observational design; no causality
Source: The Lancet Psychiatry
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
